ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149,572 | -55.3% | 27,445 | -44.9% | 0.00% | – |
Q2 2023 | $334,269 | +13.8% | 49,817 | +49.7% | 0.00% | – |
Q1 2023 | $293,779 | +59.8% | 33,270 | +38.3% | 0.00% | – |
Q4 2022 | $183,788 | +3.3% | 24,056 | -3.3% | 0.00% | – |
Q3 2022 | $178,000 | -37.1% | 24,872 | -28.8% | 0.00% | – |
Q2 2022 | $283,000 | -42.6% | 34,924 | -1.9% | 0.00% | – |
Q1 2022 | $493,000 | -25.3% | 35,603 | +51.4% | 0.00% | – |
Q4 2021 | $660,000 | -27.9% | 23,515 | -12.6% | 0.00% | – |
Q3 2021 | $915,000 | -36.6% | 26,891 | -23.9% | 0.00% | – |
Q2 2021 | $1,443,000 | -95.6% | 35,341 | -95.7% | 0.00% | -100.0% |
Q1 2021 | $32,871,000 | -58.4% | 816,458 | -39.0% | 0.01% | -63.2% |
Q4 2020 | $79,105,000 | +47.5% | 1,337,827 | +21.3% | 0.02% | +26.7% |
Q3 2020 | $53,638,000 | +21.4% | 1,102,973 | +17.8% | 0.02% | +15.4% |
Q2 2020 | $44,199,000 | +79.8% | 936,227 | +5.8% | 0.01% | +62.5% |
Q1 2020 | $24,584,000 | +275.8% | 884,934 | +304.8% | 0.01% | +300.0% |
Q4 2019 | $6,542,000 | -1.4% | 218,626 | +1.8% | 0.00% | 0.0% |
Q3 2019 | $6,636,000 | +31.1% | 214,768 | +104.9% | 0.00% | +100.0% |
Q2 2019 | $5,061,000 | – | 104,799 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |